Inhibitory Peptides
New research on inhibitory peptides from Baylor College of Medicine, Michael E. DeBakey Department of Surgery summarized
Published in Clinical Oncology Week, October 29th, 2007
New investigation results, 'Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model,' are detailed in a study published in Journal of Surgical Research. According to recent research from the United States, "'INTRODUCTION: We have recently developed two inhibitory peptides that target angiocidin, a key mediator of tumor progression and angiogenesis. In this study, we investigate the expression of angiocidin in human colon cancer specimens and evaluate the therapeutic efficacy of our angiocidin inhibitory peptides."
"We created a colon cancer tissue array containing primary tumor, normal colon, negative and positive lymph nodes, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Brain Cancer
Drug combination might offer hope for patients deadly brain tumors - Breast Cancer
Contrast agent trials in swine - Breast Cancer
Sunlight Exposure May Decrease Risk of Advanced Breast Cancer - Breast Cancer
Weight Gain Related to Postmenopausal Breast Cancer Risk - Cancer
Exercise and Psychological Counseling Could Ease Cancer-related Fatigue - Cancer
Sidestepping cancer's chaperone - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
